Spots Global Cancer Trial Database for transplant
Every month we try and update this database with for transplant cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Combination Chemotherapy and Donor Stem Cell Transplant Followed by Ixazomib Citrate Maintenance Therapy in Treating Patients With Relapsed High-Risk Multiple Myeloma | NCT02504359 | Plasma Cell Leu... Recurrent Plasm... | Allogeneic Hema... Carmustine Cytarabine Etoposide Ixazomib Citrat... Melphalan Methotrexate Peripheral Bloo... Quality-of-Life... Tacrolimus | 18 Years - 65 Years | OHSU Knight Cancer Institute | |
| Optimizing Y90 Therapy for Radiation Lobectomy | NCT04390724 | HCC Resection Transplant Metastatic Canc... Adult Primary L... | Y90 radioemboli... | 18 Years - | Northwestern University | |
| Study of Pixantrone in CD20+ Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma | NCT03458260 | Aggressive Non-... | Pixantrone Ifosfamide Etoposide Rituximab Transplant | 18 Years - | The Lymphoma Academic Research Organisation | |
| Infusion of Specially Treated Umbilical Cord Stem Cells After Chemoradiation Treatment for Blood Cancers | NCT00089596 | Acute Lymphocyt... Acute Myeloid L... Myelodysplastic... Non-Hodgkin Lym... Chronic Myeloge... | Expansion of um... | 12 Years - 60 Years | ViaCell | |
| ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals | NCT05655546 | Immunodeficienc... Immunosuppressi... HIV Infections Graft Versus Ho... Leukemia Lymphoma Cancer Multiple Myelom... Transplant Age-Related Imm... | Access to Cue H... | 18 Years - 120 Years | Scripps Translational Science Institute | |
| Phase II Study of 5-azacytidine Maintenance After Transplant for AML or MDS | NCT02204020 | Acute Myeloid L... Myelodysplastic... | 5-azacytidine (... | 18 Years - | University of Pittsburgh | |
| Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma | NCT01453101 | Multiple Myelom... | Fludarabine mon... | 18 Years - 69 Years | Hackensack Meridian Health | |
| Ph2 NK Cell Enriched DCIs w/wo RLR9 Agonist, DUK-CPG-001 From Donors Following Allogeneic SCT | NCT02452697 | Myeloid Maligna... Lymphoid Malign... | NK Cell enriche... NK-DLI + DUK-CP... | 18 Years - | Duke University | |
| Liver Transplantation After ex Vivo Liver Perfusion | NCT05951231 | Liver Transplan... Transplant; Fai... Transplant Dysf... Transplant; Com... Transplant Liver Metastase... Liver Cancer | Liver transplan... | 18 Years - 100 Years | Oslo University Hospital | |
| Escalating Doses of Thalidomide in Conjunction With Bortezomib and HIgh Dose Melphalan for BSCT | NCT01242267 | Multiple Myelom... | Thalidomide+Mel... | 18 Years - 75 Years | Hackensack Meridian Health | |
| Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies | NCT02743351 | Hematologic Mal... Acute Myeloid L... Acute Lymphobla... Myelodysplastic... Chronic Myeloge... Acute Graft-ver... | ProTmune Control Arm | 18 Years - | Fate Therapeutics | |
| Umbilical Cord Blood Transplant for Children With Myeloid Hematological Malignancies | NCT01247701 | Myeloid Hematol... | Busulfan Cyclophosphamid... Fludarabine Cord Blood Stem... | - 17 Years | Baylor College of Medicine | |
| Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma | NCT01453101 | Multiple Myelom... | Fludarabine mon... | 18 Years - 69 Years | Hackensack Meridian Health | |
| Matched Unrelated Donor Transplant for Metastatic Renal Cell Carcinoma | NCT00318110 | Metastatic Rena... | NST using MUD f... | 18 Years - 65 Years | Center for International Blood and Marrow Transplant Research | |
| Mucositis and Infection Reduction With Liquid Probiotics in Children With Cancer | NCT03785938 | Pediatric Cance... | Probiotic Placebo | 1 Year - 18 Years | University of Leeds | |
| Escalating Doses of Thalidomide in Conjunction With Bortezomib and HIgh Dose Melphalan for BSCT | NCT01242267 | Multiple Myelom... | Thalidomide+Mel... | 18 Years - 75 Years | Hackensack Meridian Health | |
| Radiotherapy Versus no Intervention in Adult Patients With Hepatocellular Carcinoma Not Eligible for Transarterial Chemoembolization or Ablation Prior to Liver Transplant (RADBRI) | NCT03172559 | Hepatocellular ... | Stereotactic bo... | 18 Years - 75 Years | University Health Network, Toronto | |
| Unrelated Donor Stem Cell Transplantation | NCT01364363 | Severe Aplastic... Paroxysmal Noct... Acute Myelogeno... Acute Lymphobla... Myelodysplastic... Myeloproliferat... Chronic Myeloge... Hodgkin's Lymph... Non-Hodgkin's L... Multiple Myelom... Chronic Lymphoc... Small Lymphocyt... Large Granulocy... | Allogeneic tran... | 18 Years - 69 Years | Scripps Health | |
| TCRαβ/CD19 Depletion of Stem Cell Grafts for Transplant | NCT05968170 | Graft Vs Host D... Graft-versus-ho... Acute Myeloid L... Acute Lymphobla... Non-hematologic... Hematologic Mal... | CliniMACS® devi... | - 21 Years | Children's Hospital Los Angeles | |
| Trial to Assess the Efficacy of a TCR Alfa Beta Depleted Graft in Pediatric Affected by ALL or AML and Receiving an HSCT | NCT01810120 | Acute Lymphobla... Leukemia Acute ... Non-Hodgkin Lym... Myelodysplastic... | TCR alfa beta T... | 3 Months - 20 Years | Bambino Gesù Hospital and Research Institute | |
| Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients | NCT03609840 | Hematologic Mal... Nonmalignant Di... Immune Deficien... Hemoglobinopath... Genetic Inborn ... Fanconi Anemia Thalassemia Sickle Cell Dis... | Thiotepa | - 17 Years | University of California, San Francisco | |
| Auto Transplant High Dose Melphalan vs High Dose Melphalan+Bortezomib in Pts With Multiple Myeloma Age 65 Years or Older | NCT01453088 | Multiple Myelom... | Melphalan Bortezomib | 60 Years - | Hackensack Meridian Health | |
| Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma | NCT00006747 | Graft Versus Ho... Lymphoma | carmustine melphalan etoposide cytarabine tacrolimus methotrexate sargramostim transplant | - 59 Years | Alliance for Clinical Trials in Oncology | |
| Bendamustine Bridge to Autologous or Allogeneic Transplant for Relapsed/Refractory Lymphoma | NCT02059239 | Hodgkin's Lymph... Non-Hodgkin's L... | Bendamustine Carmustine Etoposide Melphalan Cytarabine Alemtuzumab Autologous Stem... Allogeneic Stem... Rituximab | 18 Years - | Weill Medical College of Cornell University | |
| Infusion of Specially Treated Umbilical Cord Stem Cells After Chemoradiation Treatment for Blood Cancers | NCT00089596 | Acute Lymphocyt... Acute Myeloid L... Myelodysplastic... Non-Hodgkin Lym... Chronic Myeloge... | Expansion of um... | 12 Years - 60 Years | ViaCell | |
| Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients | NCT03609840 | Hematologic Mal... Nonmalignant Di... Immune Deficien... Hemoglobinopath... Genetic Inborn ... Fanconi Anemia Thalassemia Sickle Cell Dis... | Thiotepa | - 17 Years | University of California, San Francisco | |
| A Trial of Skeletal Targeted Radiotherapy Using Holmium-166-DOTMP in Patients With Multiple Myeloma | NCT00039754 | Multiple Myelom... | Holmium-166-DOT... | 18 Years - 70 Years | Poniard Pharmaceuticals | |
| Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT | NCT01012492 | AML ALL Undifferentiate... Biphenotypic Le... Refractory Anem... Refractory Anem... Refractory Cyto... Ref. Cytopenia ... Refractory Anem... Refractory Anem... Myelodysplastic... MDS Associated ... | Abatacept | 12 Years - | Boston Children's Hospital | |
| A Study of Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies | NCT01036009 | Acute Leukemia Acute Myeloid L... Acute Lymphobla... Biphenotypic Le... Pre-leukemic Sy... Monosomy 7 Bone Marrow Clo... Juvenile Myelom... Myelodysplastic... Chronic Myeloge... | Withdrawal of i... | 6 Months - 25 Years | University of California, San Francisco | |
| Phase III, Randomized Trial: Lenalidomide vs Observation After Induction With Rituximab Followed by Cht and ASCT in MCL Adult Patients | NCT02354313 | MANTLE CELL LYM... | Lenalidomide | 18 Years - 60 Years | Fondazione Italiana Linfomi - ETS | |
| Vaccine Responses to Influenza A H1N1/09 Immunization in High-risk Patients | NCT01022905 | HIV Infection Rheumatic Disea... Cancer Transplant Pediatrics | Adjuvanted infl... | 6 Months - | University Hospital, Geneva | |
| Nonmyeloablative Allogeneic Transplant | NCT01272817 | Aplastic Anemia Paroxysmal Noct... Acute Myelogeno... Acute Lymphocyt... Myelodysplastic... Chronic Myeloge... Chronic Lymphoc... Hodgkin's Lymph... Non-Hodgkin's L... Mantle Cell Lym... Multiple Myelom... Waldenstrom Mac... Breast Cancer Renal Cell Carc... Melanoma Sarcoma Ovarian Cancer Thymoma | Nonmyeloablativ... Nonmyeloablativ... | 18 Years - 72 Years | Scripps Health | |
| Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma | NCT01453101 | Multiple Myelom... | Fludarabine mon... | 18 Years - 69 Years | Hackensack Meridian Health | |
| Vaccine Responses to Influenza A H1N1/09 Immunization in High-risk Patients | NCT01022905 | HIV Infection Rheumatic Disea... Cancer Transplant Pediatrics | Adjuvanted infl... | 6 Months - | University Hospital, Geneva | |
| Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression | NCT03480360 | Acute Myeloid L... Chronic Lymphoc... Chronic Myeloid... Myelodysplasia Myeloproliferat... Myelofibrosis Lymphoma Lymphoma, Non-H... Plasma Cell Dis... | Cyclophosphamid... Fludarabine Total Body Irra... Tacrolimus cellcept g-csf Peripheral Bloo... | 18 Years - 75 Years | Dartmouth-Hitchcock Medical Center | |
| Infusion of Specially Treated Umbilical Cord Stem Cells After Chemoradiation Treatment for Blood Cancers | NCT00089596 | Acute Lymphocyt... Acute Myeloid L... Myelodysplastic... Non-Hodgkin Lym... Chronic Myeloge... | Expansion of um... | 12 Years - 60 Years | ViaCell | |
| Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904) | NCT04965597 | Bone Marrow Fai... Congenital Ameg... Congenital Pure... Hereditary Side... Paroxysmal Noct... Shwachman-Diamo... Hematologic Neo... Hematologic Neo... Hematologic Neo... | Treosulfan Fludarabine Pho... Tacrolimus Methotrexate Lapine T-Lympho... Peripheral Bloo... Allogeneic Bone... Quality-of-Life... Echocardiograph... Multigated Acqu... Bone Marrow Bio... Bone Marrow Asp... Biospecimen Col... | 1 Year - 49 Years | Fred Hutchinson Cancer Center | |
| Comparing Two Diets in Patients Undergoing HSCT or Remission Induction Chemo for Acute Leukemia and MDS (UF-BMT-LDND-101) | NCT03016130 | Leukemia Myelodysplastic... | Diet | 18 Years - | University of Florida | |
| Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies | NCT02323867 | Leukemia Lymphoma Myelodysplasia | Alpha Beta T ce... | - 23 Years | Children's Hospital of Philadelphia | |
| Umbilical Cord Blood Transplant for Children With Myeloid Hematological Malignancies | NCT01247701 | Myeloid Hematol... | Busulfan Cyclophosphamid... Fludarabine Cord Blood Stem... | - 17 Years | Baylor College of Medicine | |
| Mucositis and Infection Reduction With Liquid Probiotics in Children With Cancer | NCT03785938 | Pediatric Cance... | Probiotic Placebo | 1 Year - 18 Years | University of Leeds | |
| Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant | NCT01559844 | Hepatitis C Hepatocellular ... | Sofosbuvir Ribavirin | 18 Years - | Gilead Sciences | |
| Improving Blood Stem Cell Collection and Transplant Procedures | NCT01517035 | Myelodysplastic... Chronic Myeloge... Acute Lymphobla... CML (Chronic My... CLL (Chronic Ly... | Stem Cell Trans... | 2 Years - 80 Years | National Institutes of Health Clinical Center (CC) | |
| A Trial of Skeletal Targeted Radiotherapy Using Holmium-166-DOTMP in Patients With Multiple Myeloma | NCT00039754 | Multiple Myelom... | Holmium-166-DOT... | 18 Years - 70 Years | Poniard Pharmaceuticals | |
| Fludarabine and Alemtuzumab or Cyclophosphamide Followed by Peripheral Blood Stem Cell Transplant or Alemtuzumab in Treating Patients With Advanced or Progressive Chronic Lymphocytic Leukemia | NCT00462332 | Leukemia | Fludarabine Campath Transplant Campath Fludarabine Campath Campath | - 60 Years | Gruppo Italiano Malattie EMatologiche dell'Adulto | |
| Bendamustine Bridge to Autologous or Allogeneic Transplant for Relapsed/Refractory Lymphoma | NCT02059239 | Hodgkin's Lymph... Non-Hodgkin's L... | Bendamustine Carmustine Etoposide Melphalan Cytarabine Alemtuzumab Autologous Stem... Allogeneic Stem... Rituximab | 18 Years - | Weill Medical College of Cornell University | |
| Pevonedistat and Azacitidine as Maintenance Therapy After Allogeneic Stem Cell Transplantation for Non-Remission AML | NCT03709576 | Acute Myeloid L... | Pevonedistat transplant Azacitidine | 18 Years - 70 Years | Milton S. Hershey Medical Center | |
| Use of T-allo10 in Hematopoietic Stem Cell Transplantation (HSCT) for Blood Disorders | NCT03198234 | AML - Acute Mye... MDS (Myelodyspl... Mixed Phenotype... NHL - Non-Hodgk... Hodgkin's Lymph... ALL | T-allo10 | 3 Years - 45 Years | Stanford University | |
| D.T. PACE Versus High Dose Melphalan and Autologous Transplant in Patients With Previously Treated Multiple Myeloma | NCT00083876 | Multiple Myelom... | Thalidomide | 18 Years - | University of Arkansas | |
| Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation | NCT00328237 | Acute Myeloid L... Acute Lymphobla... Chronic Myeloid... Non-Hodgkin Lym... Myelodysplastic... | Cord Blood Tran... | 18 Years - 49 Years | Colorado Blood Cancer Institute | |
| Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT | NCT01012492 | AML ALL Undifferentiate... Biphenotypic Le... Refractory Anem... Refractory Anem... Refractory Cyto... Ref. Cytopenia ... Refractory Anem... Refractory Anem... Myelodysplastic... MDS Associated ... | Abatacept | 12 Years - | Boston Children's Hospital | |
| Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients | NCT00415584 | Secondary Hyper... Hypercalcemia | Cinacalcet HCl | 18 Years - | Montefiore Medical Center | |
| A Safety Study Looking at the Combination of Velcade and G-CSF in Patients With Myeloma or Lymphoma | NCT01171092 | Malignant Lymph... Autologous Tran... | bortezomib and ... | 18 Years - | University of Kansas Medical Center | |
| Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies | NCT02323867 | Leukemia Lymphoma Myelodysplasia | Alpha Beta T ce... | - 23 Years | Children's Hospital of Philadelphia | |
| AML Treatment in Untreated Adult Patients | NCT00449319 | Leukemia, Myelo... | Identification ... Daunorubicine Transplant | 15 Years - 61 Years | Gruppo Italiano Malattie EMatologiche dell'Adulto | |
| A Safety Study Looking at the Combination of Velcade and G-CSF in Patients With Myeloma or Lymphoma | NCT01171092 | Malignant Lymph... Autologous Tran... | bortezomib and ... | 18 Years - | University of Kansas Medical Center | |
| Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant | NCT05027425 | Hepatocellular ... Cirrhosis Portal Hyperten... | Durvalumab Tremelimumab Liver Transplan... | 18 Years - | University of Cincinnati | |
| UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy | NCT00083551 | Multiple Myelom... | Thalidomide Ara-C BCNU Cisplatin Cytoxan Dexamethasone Doxorubicin Etoposide Filgrastim Recombinant GM-... Interferon-alph... Melphalan Vincristine | 18 Years - 75 Years | University of Arkansas | |
| Stem Cell Translpantation in Multiple Myeloma | NCT05082675 | Multiple Myelom... | HLA Matched all... | 18 Years - 70 Years | European Society for Blood and Marrow Transplantation | |
| Sirolimus in Kidney Transplant Patients With Squamous Cell Skin Carcinoma | NCT01764607 | Squamous Cell S... | Sirolimus | 18 Years - | University of Florida | |
| Study of MAGE-A3 and NY-ESO-1 Immunotherapy in Combo With DTPACE Chemo and Auto Transplantation in Multiple Myeloma | NCT00090493 | Multiple Myelom... | MAGE-A3 MAGE-A3 AND NY-... | 18 Years - 70 Years | University of Arkansas | |
| Bendamustine Bridge to Autologous or Allogeneic Transplant for Relapsed/Refractory Lymphoma | NCT02059239 | Hodgkin's Lymph... Non-Hodgkin's L... | Bendamustine Carmustine Etoposide Melphalan Cytarabine Alemtuzumab Autologous Stem... Allogeneic Stem... Rituximab | 18 Years - | Weill Medical College of Cornell University | |
| Escalating Doses of Thalidomide in Conjunction With Bortezomib and HIgh Dose Melphalan for BSCT | NCT01242267 | Multiple Myelom... | Thalidomide+Mel... | 18 Years - 75 Years | Hackensack Meridian Health | |
| AML Treatment in Untreated Adult Patients | NCT00449319 | Leukemia, Myelo... | Identification ... Daunorubicine Transplant | 15 Years - 61 Years | Gruppo Italiano Malattie EMatologiche dell'Adulto | |
| Comparing Two Diets in Patients Undergoing HSCT or Remission Induction Chemo for Acute Leukemia and MDS (UF-BMT-LDND-101) | NCT03016130 | Leukemia Myelodysplastic... | Diet | 18 Years - | University of Florida | |
| Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies | NCT02323867 | Leukemia Lymphoma Myelodysplasia | Alpha Beta T ce... | - 23 Years | Children's Hospital of Philadelphia | |
| Study Evaluating the Effect of Sirolimus on Non-Melanoma Skin Cancer in Kidney Transplant Recipients | NCT00129961 | Skin Neoplasms Kidney Transpla... | sirolimus cyclosporine or... | 18 Years - | Wyeth is now a wholly owned subsidiary of Pfizer | |
| Improving Blood Stem Cell Collection and Transplant Procedures | NCT01517035 | Myelodysplastic... Chronic Myeloge... Acute Lymphobla... CML (Chronic My... CLL (Chronic Ly... | Stem Cell Trans... | 2 Years - 80 Years | National Institutes of Health Clinical Center (CC) | |
| PD-1 Antibody for Reactive EBV After BMT | NCT04690036 | PD-1 EBV Infection Transplant | toripalimab inj... | 18 Years - | Beijing Friendship Hospital | |
| Study of Gelonin Purging of Autologous Stem Cells for Transplantation | NCT00043810 | Acute Myelogeno... Myelodysplastic... | Gelonin Busulfan Fludarabine | - | M.D. Anderson Cancer Center | |
| Carfilzomib With Bendamustine and Dexamethasone in Multiple Myeloma | NCT02002598 | Multiple Myelom... | Bendamustine Carfilzomib Dexamethasone | 18 Years - | Columbia University | |
| PD-1 Antibody for Reactive EBV After BMT | NCT04690036 | PD-1 EBV Infection Transplant | toripalimab inj... | 18 Years - | Beijing Friendship Hospital | |
| Study of KIR-Ligand Mismatched Haplo-Identical Natural Killer Cells Transfused Before Autologous Stem Cell Transplant | NCT00089453 | Multiple Myelom... | Dexamethasone Cyclophosphamid... Melphalan Fludarabine Bortezomide Leukapheresis Interleukin Infusion #1 Leukapheresis #... Infusion #2 Auto Graft | 18 Years - | University of Arkansas | |
| Targeted Radiotherapy in HSCT for Poor Risk Haematological Malignancy | NCT01521611 | Acute Leukaemia Chronic Leukaem... Myeloma Lymphoma | Targeted radiot... | 18 Years - 75 Years | University Hospital Southampton NHS Foundation Trust | |
| Stem Cell Translpantation in Multiple Myeloma | NCT05082675 | Multiple Myelom... | HLA Matched all... | 18 Years - 70 Years | European Society for Blood and Marrow Transplantation | |
| Unrelated Donor Stem Cell Transplantation | NCT01364363 | Severe Aplastic... Paroxysmal Noct... Acute Myelogeno... Acute Lymphobla... Myelodysplastic... Myeloproliferat... Chronic Myeloge... Hodgkin's Lymph... Non-Hodgkin's L... Multiple Myelom... Chronic Lymphoc... Small Lymphocyt... Large Granulocy... | Allogeneic tran... | 18 Years - 69 Years | Scripps Health | |
| Phase III, Randomized Trial: Lenalidomide vs Observation After Induction With Rituximab Followed by Cht and ASCT in MCL Adult Patients | NCT02354313 | MANTLE CELL LYM... | Lenalidomide | 18 Years - 60 Years | Fondazione Italiana Linfomi - ETS | |
| Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant | NCT05027425 | Hepatocellular ... Cirrhosis Portal Hyperten... | Durvalumab Tremelimumab Liver Transplan... | 18 Years - | University of Cincinnati | |
| Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant | NCT01559844 | Hepatitis C Hepatocellular ... | Sofosbuvir Ribavirin | 18 Years - | Gilead Sciences |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
